Inhaled Nitric Oxide for Persistent Pulmonary Hypertension Clinical Pathway — N/IICU

Goal

To standardize the approach to treating newborns with persistent pulmonary hypertension requiring inhaled nitric oxide (iNO) in the N/IICU.

Metrics

  • Number of cohort patients whose iNO management followed pathway recommendations.
  • Number of cohort patients whose iNO management did not follow pathway recommendations, but for acceptable clinical reasons (determined by chart review and clinician interviews).